The original article contained incorrect contact details for the corresponding author. The correct details are provided here.
In Section 3.4, the uppercase P indicating the significance for Cochran’s Q test should be a lowercase p. This sentence should read as follows: Neither Cochran’s Q test (p = 0.360) nor the I2 statistic (9%) indicated the presence of heterogeneity among these studies.
Conflicts of interest: The authors have nothing to disclose.
Article info
Publication history
Published online: December 19, 2022
Identification
Copyright
© 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysisEuropean Urology Open ScienceVol. 39
- PreviewTake Home Message High body mass index appears to be associated with lower mortality among patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors. The role of overweight/obesity in the clinical consequences of mRCC should be extensively investigated in terms of host-related factors and the tumour immune microenvironment.
- Full-Text
- Preview
